DUBLIN--(BUSINESS WIRE)--The "Large Volume Wearable Injectors Market (4th Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering.
Large Volume Wearable Injectors Market (4th Edition), 2018-2030 report features an extensive study of the current market landscape and the likely future evolution of self-injection devices, over the next twelve years.
It specifically lays emphasis on the emergence of patient-centric, convenient, cost-effective and user-friendly wearable drug delivery solutions that are capable of administering large volumes of a drug subcutaneously, in the home-care setting.
Large volume wearable injectors are capable of drug delivery primarily via the subcutaneous route and have become a preferred choice for the administration of drugs in the home-care setting.
Variants of these wearable devices have been designed to administer highly viscous drugs (such as most biologics) in large volumes (more than 1 ml), offering numerous benefits, such as ease-of-use, reduced chances of dosing-related errors, integrated safety mechanisms, and almost negligible risk of needlestick injuries.
It is worth highlighting that such devices have captured the interest of several stakeholders in this industry to deliver various insulin and non-insulin drugs.
Moreover, the field is witnessing emergence of other technological advancements, such as integrated mobile applications with smart health monitoring and other interesting features (such as provisions for reminders, and the ability to connect to web-based portals for sharing medical data with the concerned healthcare providers), visual / audible drug delivery confirmation notifications, automatic drug reconstitution, and error alerts.
Topics Covered
1. Preface
2. Executive Summary
3. Introduction
4. Large Volume Wearable Injectors: Current Market Landscape
5. Product Competitiveness Analysis
6. Large Volume Wearable Injectors: Key Players
7. Drug-Device Combinations: Tabulated Profiles
8. Patent Analysis
9. Emerging Trends on Social Media
10. Clinical Trial Analysis
11. Case Study: Role of CMOS in Device Development Supply Chain
12. Large Volume Wearable Injectors: Likely Drug Candidates
13. Market Sizing and Opportunity Analysis
14. Future Growth Opportunities
15. Executive Insights
Companies Featured
- 3M
- Abbott
- AbbVie
- AbGenomics
- Aduro BioTech
- Advaxis
- Aeglea BioTherapeutics
- Affibody
- Affimed
- Agenus
- Asklepion Pharmaceuticals
- Astellas Pharma
- AstraZeneca
- Atridia
- AVEO Pharmaceuticals
- Axon Neuroscience
- Bang & Olufsen Medicom
- Baril
- Battelle
- Baxter International
- Bayer
- Medtronic
- Medtrum Technologies
- Menarini Group
- Merck
- Merck Sharp & Dohme
- miRagen Therapeutics
- Moderna Therapeutics
- Mylan
- NantBioScience
- Naurex
- Ypsomed
- Zafgen
- Zollner
-
and many more...
For more information about this report visit https://www.researchandmarkets.com/research/h9lxq4/global_large?w=4
